PMID- 32520445 OWN - NLM STAT- MEDLINE DCOM- 20210319 LR - 20210319 IS - 1542-4758 (Electronic) IS - 1492-7535 (Print) IS - 1492-7535 (Linking) VI - 24 IP - 3 DP - 2020 Jul TI - Effect of long-term use of unfractionated or low-molecular-weight heparin on bone mineral density in maintenance hemodialysis patients. PG - 374-382 LID - 10.1111/hdi.12854 [doi] AB - INTRODUCTION: Long-term use of unfractionated heparin (UFH) or low-molecular-weight heparin (LMWH) causes bone loss and osteoporosis in patients not receiving hemodialysis. This study aimed to investigate the effect of UFH and LMWH on bone mineral density (BMD) in patients undergoing maintenance hemodialysis (MHD). METHODS: Patients undergoing MHD using UFH or LMWH as anticoagulants were enrolled. BMD (in g/cm(2) ), T-score and Z-score (BMDs) were measured at the lumbar spine and femur neck using dual-energy X-ray absorptiometry (DXA) at baseline and 2 years later. Patient demographics and clinical indices were collected. Correlation analysis was used to identify significant predictors of bone loss. Multiple linear regression was used to explore the relationship between heparin type and bone loss progression. FINDINGS: A total of 104 patients were enrolled and completed the baseline BMD test; 72 completed the test again 2 years later. Six patients were excluded because they used both UFH and LMWH. Although BMD decreased in some patients in the UFH group, a slight increase in the BMD was observed on an average in the LMWH group after 2 years. The mean change in BMD (in g/cm(2) ) [0(-0.03,0.04) vs. 0.04(0,0.06), P = 0.023], T-score [0(-0.40,0.30) vs. 0.35(-0.03,0.53), P = 0.038], and Z-score [0.10(-0.30,0.40) vs. 0.45(0.08,0.63), P = 0.031] in the lumbar spine in the UFH group was lower than those in the LMWH group. Femur neck BMD did not change significantly. In a linear regression model, after adjusting for diabetes mellitus, parathyroid hormone, and serum phosphate, we did not find an association between heparin substances and BMD. DISCUSSION: UFH might be associated with loss of lumbar spine BMD in patients undergoing MHD. CI - (c) 2020 The Authors. Hemodialysis International published by Wiley Periodicals LLC on behalf of International Society for Hemodialysis. FAU - Yang, Shuo AU - Yang S AD - Department of Nephrology, Peking University People's Hospital, Beijing, China. FAU - Niu, Qingyu AU - Niu Q AD - Department of Nephrology, Peking University People's Hospital, Beijing, China. FAU - Gan, Liangying AU - Gan L AD - Department of Nephrology, Peking University People's Hospital, Beijing, China. FAU - Zhang, Xiaobo AU - Zhang X AD - Department of Nephrology, Peking University People's Hospital, Beijing, China. FAU - Tu, Lingxue AU - Tu L AD - Department of Nephrology, Peking University People's Hospital, Beijing, China. FAU - Zuo, Li AU - Zuo L AD - Department of Nephrology, Peking University People's Hospital, Beijing, China. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20200610 PL - Canada TA - Hemodial Int JT - Hemodialysis international. International Symposium on Home Hemodialysis JID - 101093910 RN - 0 (Heparin, Low-Molecular-Weight) SB - IM MH - Bone Density/*drug effects MH - Cohort Studies MH - Female MH - Heparin, Low-Molecular-Weight/*adverse effects MH - Humans MH - Male MH - Middle Aged MH - Osteoporosis/*chemically induced MH - Prospective Studies MH - Renal Dialysis/*adverse effects PMC - PMC7496178 OTO - NOTNLM OT - Hemodialysis OT - bone mineral density OT - heparin OT - low-molecular-weight heparin OT - osteoporosis EDAT- 2020/06/11 06:00 MHDA- 2021/03/20 06:00 PMCR- 2020/09/17 CRDT- 2020/06/11 06:00 PHST- 2019/11/26 00:00 [received] PHST- 2020/04/20 00:00 [revised] PHST- 2020/04/30 00:00 [accepted] PHST- 2020/06/11 06:00 [pubmed] PHST- 2021/03/20 06:00 [medline] PHST- 2020/06/11 06:00 [entrez] PHST- 2020/09/17 00:00 [pmc-release] AID - HDI12854 [pii] AID - 10.1111/hdi.12854 [doi] PST - ppublish SO - Hemodial Int. 2020 Jul;24(3):374-382. doi: 10.1111/hdi.12854. Epub 2020 Jun 10.